Method of Differentiation from Human Pluripotent Stem Cells to Monohormonal Cells

Principal Investigator: 

Shuibing Chen, Kilts Family Professor of Surgery

Benefits

  • Monohormonal β-cell transplant would have the ability to cure the disease, compared to current treatments which solely supplement insulin and insulin production.
  • The invention allows almost homogenous preparations of monohormonal cells compared to previous differentiation methods.

Potential Applications

  • Transplant of monohormonal cells into the pancreas of diabetes patients to secrete insulin.
  • Drug screening platform to identify candidates to treat diabetes.

Intellectual Property

Patents

  • PCT Application: WO2007135563A3: Use of glis3 for preparing functional pancreatic beta-cells.

Cornell Reference 

  • 8250

Contact Information

Louise Sarup, Ph.D

For additional information please contact

Louise Sarup
Associate Director, Business Development and Licensing
Phone: (646) 962-3523
Email: lss248@cornell.edu